Latest Prescription Drugs news
FDA Approves New Antibody Drug to Fight Omicron Variant
posted February 11th
by modernClinician Editorial Team
by modernClinician Editorial Team
Adding Tirzepatide to Insulin Glargine Ups Glycemic Control in T2DM
posted February 10th
by modernClinician Editorial Team
by modernClinician Editorial Team
Cemiplimab Prolongs Survival in Recurrent Cervical Cancer
posted February 10th
by modernClinician Editorial Team
by modernClinician Editorial Team
Neoadjuvant Pembrolizumab Plus Chemo Treats Early TNBC
posted February 10th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy 
Gap Found Between Awareness of Breast Cancer Risk and Risk-Reducing Behavior Related Articles
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria Monthly Specialist Briefings
Stay Connected
